Treatment experience in patients with anti-myelin-associated glycoprotein neuropathy

Muscle and Nerve

Volumn 24, Issue 6, 2001, Pages 778-786

  Gorson, Kenneth C ^a   Ropper, Allan H ^a   Weinberg, David H ^a   Weinstein, Robert ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti myelin associated glycoprotein (anti MAG) antibody; Intravenous immunoglobulin (IVIg); Neuropathy; Paraprotein; Plasma exchange (PE); Therapy

Indexed keywords

ALPHA2A INTERFERON; AUTOANTIBODY; AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; GLYCOPROTEIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYELIN;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; DISABILITY; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MALE; MUSCLE STRENGTH; NERVE CONDUCTION; NEUROPATHY; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CYCLOPHOSPHAMIDE; ELECTROPHYSIOLOGY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; MALE; MIDDLE AGED; MOTOR NEURONS; MYELIN-ASSOCIATED GLYCOPROTEIN; NEURAL CONDUCTION; NEURONS, AFFERENT; PLASMA EXCHANGE; POLYNEUROPATHIES; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 0035000379     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1069     Document Type: Article

References (48)

1. Albers JW, Kelly JJ. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-451.
2. Blume G, Pestronk A, Goodnough I.T. Anti-MAG antibody associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide. Neurology 1995;45:1577-1580.
3. Cook D, Dalakas M, Galdi A, Biondi D, Porter H. High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy. Neurology 1990;40:212-214.
4. Cornblath DR, Asbury AK, Albers JW, Feasby TE, Hahn AF, McLeod JG, Mendell JR, Parry GJ, Pollard JD, Thomas PK. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991;41:617-618.
5. Dalakas MC, Engel WK. Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Ann Neurol 1981;10: 45-52.
6. Dalakas, MC, Quarles RH, Farrer RG, Dambrosia J, Soueidan S, Stein DP, Cupler E, Sekul EA, Otero C. A controlled study of intravenous gammaglobulin in demyelinating neuropathy with IgM gammopathy. Ann Neurol 1996;40:792-795.
7. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ, O'Brien PC, Litchy WJ, Windebank AJ, Smith BE, Low PA. The Rochester diabetic neuropathy study: design criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991:41:799-807.
8. Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J. Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological, pathological findings and response to treatment in 33 cases. J Neurol 1996;243:34-43.
9. Ernerudh J. Brodtkorb E, Olsson T, Vedeler CA, Nyland H, Berlin G. Peripheral neuropathy and monoclonal IgM with antibody activity against peripheral nerve myelin: effect of plasma exchange. J Neuroimmunol 1986;11:171-178.
10. Ernerudh JH, Vrethem M, Anderson O, Lindberg C, Berlin G. Immunochemical and clinical effects of immunosuppressive treatment in monoclonal IgM neuropathy. J Neurol Neurosurg Psychiatry 1992;55:930-934.
11. Hass DC, Tatum AH. Plasmapheresis alleviates neuropathy accompanying IgM anti-myelin-associated glycoprotein paraproteinemia. Ann Neurol 1988;23:394-396.
12. Hays AP, Latov N, Takatsu M, Sherman WH. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology 1987;37:242-256.
13. Hoang-Xuan K, Leger JM, Ben Younes-Chennoufi A, Saidi H, Bouche P, Bauman N, Brunet P. Traitement des neuropathies dysimmunitaires par immunoglobulines polyvalentes intraveineuses. Rev Neurol (Paris) 1993;149:385-392.
14. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without monoclonal gammopathy. Neurology 1997;48:321-328.
15. Katz JS, Saperstein DS, Gronseth G, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy. Neurology 2000;54:615-620.
16. Kelly JJ, Adelman LS, Berkman E, Bhan I. Polyneuropathies associated with IgM monoclonal gammopathies. Arch Neurol 1988;45:1355-1359.
17. Latov N, Hays AP, Sherman WH. Peripheral neuropathy and anti-MAG antibodies. Crit Rev Neurobiol 1988;3:301-332.
18. Levine TD, Pestronk A. IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab. Neurology 1999;52:1701-1704.
19. Mariette X, Brouet JC, Chevret S, Leger JM, Clavelou P, Pouget J, Vallat JM, Vial C. A randomized double-blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM. J Neurol Neurosurg Psychiatry 2000;69:279-280.
20. Mariette X, Chastang C, Clavelou P, Louboutin JP, Leger JM, Brouet JC. A randomised clinical trial comparing interferon-alpha and intravenous gammaglobulin in polyneuropathy associated with monoclonal IgM. J Neurol Neurosurg Psychiatry 1997;63:28-34.
21. Meier C, Roberts K, Steck A, Hess C, Miloni E, Tschopp L. Polyneuropathy in Waldenstrom's macroglobulinemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis. Acta Neuropathol 1984;64: 297-307.
22. Melmed C, Frail D, Duncan I, Braun P, Danoff D, Finlayson M, Stewart J. Peripheral neuropathy with IgM kappa monoclonal immunoglobulin directed against myelin-associated glycoprotein. Neurology 1983;33:1397-1405.
23. Meucci N, Cappellari A, Barbieri S, Scarlato G, Nobile-Orazio E. Long-term effects of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 1997;63:765-769.
24. Molenaar DS, Vermeulen M, de Visser M, de Haan R. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies. Neurology 1999;52:151-156.
25. Monaco S, Bonetti B, Ferrari S, Moretto G, Nardelli E, Tedesco F, Mollnes TE, Nobile-Orazio E, Manfredini E, Bonazzi L, Rizzuto N. Complement-mediated demyelination in patients with IgM monoclonal gammopathy and polyneuropathy. N Engl J Med 1990;322:649-652.
26. Nobile-Orazio E. Neuropathies associated with anti-MAG antibodies and IgM monoclonal gammopathies. In: Latov N, Wokke JHJ, Kelly JJ Jr, editors. Immunology and infectious diseases of the peripheral nerves. Cambridge: Cambridge University Press; 1998. p 168-189.
27. Nobile-Orazio E, Baldini L, Barbieri S, Marmiroli P, Spagnol G, Francomano E, Scarlato G. Treatment of patients with neuropathy and anti-MAG IgM M-proteins. Ann Neurol 1988; 24:93-97.
28. Nobile-Orazio E, Manfredini E, Carpo M, Meucci N, Monaco S, Ferrari S, Bonetti B, Cavaletti G, Gemignani F, Durelli L. Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol 1994;36:416-424.
29. Nobile-Orazio E, Meucci N, Baldini L, Di Troia A, Scarlato G. Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 2000;123:710-717.
30. Notermans NC, Franssen H, Eurelings M, van der Graff Y, Wokke JHJ. Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy. Muscle Nerve 2000;23:73-79.
31. Notermans NC, Lokhorst HM, Franssen H, Van der Graaf Y, Teunissen LL, Jennekens FGI, Van den Berg I.H. Wokke JHJ. Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. Neurology 1996;47:1227-1233.
32. Notermans NC, Vermeulen M, Lokhorst HM, van Doorn PA, van den Berg LH, Teunissen LL, Wokke JH. Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy. J Neurol 1997;244:462-463.
33. Oksenhendler E, Chrevet S, Leger JM, Louboutin JP, Bussel A, Brouet JC, for the IgM-associated Polyneuropathy Study Group. Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. J Neurol Neurosurg Psychiatry 1995;59:243-247.
34. Pestronk A, Li F, Griffin J, Feldman EL, Cornblath D, Trotter J, Zhu S, Yee WC, Phillips D, Peeples DM, Winslow BS. Polyneuropathy syndromes associated with serum antibodies to sulfatide and myelin-associated glycoprotein. Neurology 1991; 41:357-362.
35. Pestronk A, Li F, Bieser K, Choksi R, Whitton A, Kornberg AJ, Goldstein JM, Yec WC. Anti-MAG antibodies: major effects of antigen purity and antibody cross-reactivity on ELISA results and clinical correlation. Neurology 1994;44:1131-1137.
36. Ritz MF, Erne B, Ferracin F, Vital A, Vital C, Steck AJ. Anti-MAG IgM penetration into myelinated libers correlates with the extent of myelin widening. Muscle Nerve 1999;22: 1030-1037.
37. Sherman WH, Latov N, Lange DE, Hays R, Younger D. Fludarabine for IgM antibody mediated neuropathies. Ann Neurol 1994;36:326-327.
38. Simovic D, Gorson KC, Ropper AH. Comparison of IgM-MGUS and IgG-MGUS polyneuropathy. Acta Neurol Scand 1998;97:194-200.
39. Smith IS. The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Brain 1994;117: 949-957.
40. Smith T, Sherman W, Olarte MR, Lovelace RE. Peripheral neuropathy associated with plasma cell dyscrasia. Acta Neurol Scand 1987;75:244-248.
41. Takatsu M, Hays AP, Latov N, Abrams GM, Sherman WH, Nemni R, Nobile-Orazio E, Saito T. Immunofluorescence study of patients with neuropathy and IgM M-proteins. Ann Neurol 1985;18:173-181.
42. Tatum AH. Experimental paraprotein neuropathy; demyelination by passive transfer of human IgM anti-myelin-associated glytoprotein. Ann Neurol 1993;33:502-506.
43. Van den Berg LH, Hays AP, Nobile-Orazio E, Kinsella LJ, Manfredini E, Corbo M, Rosoklija G, Younger DS, Lovelace RF, Trojaborg W, Lange DE, Goldstein S, Delfiner JS, Sadiq SA, Sherman WH, Latov N. Anti-MAG and anti-SGPG antibodies in neuropathy. Muscle Nerve 1996;19:637-643.
44. Van der Meché FGA, van Doorn PA. Guillain-Barré syndrome and chronic inflammatory demyelinaling polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995;37(suppl 1):S14-S31.
45. Weinstein R, Sato PTS, Shelton K, Hartigan N, Ropper AH, Haves M, Cardillo K. Successful management of paraprotein-associated peripheral polyneuropathies by immunoadsorption of plasma with staphylococcal protein A. J Clin Apheresis 1993;8:72-77.
46. Weiss MD, Dalakas MC, Lauter CJ, Willison HJ, Quarles RH. Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia. J Neuroimmunol 1999;95:174-184.
47. Willison HJ, Trapp BD, Bacher JD, Dalakas MC, Griffin JW, Quarles RH. Demyelination induced by intraneural injection of human anti-myelin-associated glycoprotein antibodies. Muscle Nerve 1988; 11:1169-1176.
48. Wilson HC, Lunn MPT, Schey S, Hughes RAC. Successful treatment of IgM paraproteinaemic neuropathy with Fludarabine. J Neurol Neurosurg Psychiatry 1999;66:575-580.